{
    "SPADE_UN_15230": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15230",
            "Peptide Name": "PB1 (391–400)",
            "Source": "Synthetic construct",
            "Family": "Orthomyxoviridae",
            "Gene": "Not found",
            "Sequence": "KIRPLLVEGT",
            "Sequence Length": 10,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=71 ± 3μM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C51H92N14O14",
            "Mass": 1125.36,
            "PI": 8.75,
            "Net Charge": 1,
            "Hydrophobicity": 0.17,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.",
            "Literature": [
                {
                    "Title": "Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.",
                    "Pubmed ID": "25446335",
                    "Reference": "Antiviral Res. 2015 Jan;1134-10.",
                    "Author": "Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25446335"
                }
            ],
            "Frequent Amino Acids": "LEG",
            "Absent Amino Acids": "ACDFHMNOQSUWY",
            "Basic Residues": 2,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 5,
            "Polar Residues": 4,
            "Positive Residues": 2,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00305",
                    "Similarity": 1.0,
                    "Sequence": "AISCGQVSSALSPCISYARGNGAKPPAACCSGVKRLAGAAQSTADKQAACKCIKSAAGGLNAGKAAGIPSMCGVSVPYAISASVDCSKIR"
                },
                {
                    "SPADE_ID": "SPADE_N_00306",
                    "Similarity": 1.0,
                    "Sequence": "AISCGQVSSALSPCISYARGNGAKPPVACCSGVKRLAGAAQSTADKQAACKCIKSAAGGLNAGKAAGIPSMCGVSVPYAISASVDCSKIR"
                },
                {
                    "SPADE_ID": "SPADE_N_01011",
                    "Similarity": 1.0,
                    "Sequence": "AISCGQVSSALSPCISYARGSGSSPPAACCSGVRSLAGAARSTADKQAACKCIKSAAGGLNAGKAAGIPSKCGVSIPYAISSSVDCSKIR"
                }
            ]
        }
    }
}